Key result
Echocardiography is an established and widely available imaging technique for the diagnosis, prognosis, and monitoring of cardiovascular complications in autoimmune rheumatic diseases.
Why the study?
Autoimmune rheumatic diseases frequently affect the heart and vessels, making echocardiography crucial for identifying cardiovascular manifestations, determining prognosis, and monitoring treatment impact.
This review highlights the critical role of multimodality echocardiography in diagnosing, prognosticating, and monitoring cardiovascular complications in patients with autoimmune rheumatic diseases.
Answers are grounded in this paper and cite their sources.
Echocardiography detects cardiovascular complications in autoimmune rheumatic diseases; leaves open whether routine prognostic use improves outcomes.
Autoimmune rheumatic diseases are systemic diseases frequently affecting the heart and vessels. The main cardiovascular complications are pericarditis, myocarditis, valvular disease, obstructive coronary artery disease and coronary microcirculatory dysfunction, cardiac failure and pulmonary hypertension. Echocardiography, including transthoracic two and three-dimensional echocardiography, Doppler imaging, myocardial deformation and transesophageal echo, is an established and widely available imaging technique for the identification of cardiovascular manifestations that are crucial for prognosis in rheumatic diseases. Echocardiography is also important for monitoring the impact of drug treatment on cardiac function, coronary microcirculatory function, valvular function and pulmonary artery pressures. In this article we summarize established and evolving knowledge on the role of echocardiography for diagnosis and prognosis of cardiovascular abnormalities in rheumatic diseases.
No takes yet. Share an insight, caveat, or question.
Makavos et al. (2020) conducted a review in Autoimmune rheumatic diseases. Echocardiography was evaluated. Echocardiography is an established and widely available imaging technique for the diagnosis, prognosis, and monitoring of cardiovascular complications in autoimmune rheumatic diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: